Showing 12,881 - 12,900 results of 52,235 for search '(( a ((((larger decrease) OR (mean decrease))) OR (linear decrease)) ) OR ( a largest decrease ))', query time: 0.96s Refine Results
  1. 12881
  2. 12882
  3. 12883

    Effect of partial Glo-I inhibition by EP on LPS-induced production of TNF-α, collagen-I and α-SMA in HSC. by Marcus Hollenbach (376231)

    Published 2017
    “…Co-treatment of LPS and EP indicated significant dose-dependent reduction of LPS-induced markers of inflammation <b>(A1)</b> and fibrosis <b>(B1, C1)</b>. Presence of LPS and treatment with low-level concentrations of MGO (indicating partial inhibition of Glo-I activity without complete enzyme inhibition) showed significant decrease of LPS-induced release of TNF-α (absence vs. presence of 10mM MGO: 371.8±22.7 vs. 60.9±11.2 pg/ml; p<0.001), collagen-I (10.0±0.3 vs. 1.8±0.5 ng/ml; p<0.001) and α-SMA (68.6±3.6 vs. 43.8±2.2 ng/ml; p<0.001) <b>(A2, B2, C2)</b>. …”
  4. 12884
  5. 12885

    Kinetic analysis of inorganic phosphate transport in oocytes expressing NPT2a or co-expressing NPT2a and CFTR. by Naziha Bakouh (171145)

    Published 2012
    “…Data were fitted to the modified Hill equation. Results, as means ± SD, were as follows: the apparent K<sub>m</sub> for Na<sup>+</sup> substrate was 40.7 ± 14.6 in NPT2a-oocytes, not different from 41.8 ± 13.4 mM in NPT2a+CFTR-oocytes; IPi<sub>max</sub> was decreased by 39±7% in NPT2a+CFTR-oocytes compared to NPT2a-oocytes (P < 0.05). …”
  6. 12886

    Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment-3 by Iliya Lefterov (73826)

    Published 2011
    “…Values (means ± SEM) are fold of wild type, vehicle treated cells of at least two independent experiments. …”
  7. 12887
  8. 12888
  9. 12889
  10. 12890
  11. 12891
  12. 12892

    Supplementary Figure 1 by Rajesh Gupta (65584)

    Published 2022
    “…Fasting (and incubation in 100 µM nicotinic acid) led to a significant decrease in the PPR in GPR109A+/+ mice (as seen in C57BL/6J mice; compare with Figure 6A). …”
  13. 12893
  14. 12894
  15. 12895

    Efficacy and Safety of Abciximab in Diabetic Patients Who Underwent Percutaneous Coronary Intervention with Thienopyridines Loading: A Meta-Analysis by Yihua Wu (218686)

    Published 2011
    “…The only beneficial effect by abciximab appeared to be a decrease 1-year TLR (target lesion revascularization) risk in elective-PCI patients (RR1-year: 0.83, 95% CI: 0.70–0.99). …”
  16. 12896

    Altered Theca and Cumulus Oocyte Complex Gene Expression, Follicular Arrest and Reduced Fertility in Cows with Dominant Follicle Follicular Fluid Androgen Excess by Adam F. Summers (645799)

    Published 2014
    “…<div><p>Aspiration of bovine follicles 12–36 hours after induced corpus luteum lysis serendipitously identified two populations of cows, one with High androstenedione (A4; >40 ng/ml; mean = 102) and another with Low A4 (<20 ng/ml; mean = 9) in follicular fluid. …”
  17. 12897

    Data_Sheet_1_Seasonal Photosynthesis, Respiration, and Calcification of a Temperate Maërl Bed in Southern Portugal.doc by Laura Sordo (8596947)

    Published 2020
    “…To characterize the seasonal and interannual patterns of key abiotic conditions in the largest described maërl bed of the Portuguese coast, temperature, irradiance, and dissolved oxygen were continuously monitored over a 2-year period. …”
  18. 12898

    Table_1_Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a... by Arthur Allignol (4017428)

    Published 2021
    “…</p><p>Results: Of the 5,340 patients included in the analysis, there was a high proportion of patients free from relapse across all age groups (range: 94.1–95.4%), with a numerical decrease in the number of MRI performed by age (mean: 0.25, 18–30 years; 0.20, 31–40 years; 0.16, 41–50 years; 0.14, ≥51 years). …”
  19. 12899

    Table_1_Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a... by Arthur Allignol (4017428)

    Published 2021
    “…</p><p>Results: Of the 5,340 patients included in the analysis, there was a high proportion of patients free from relapse across all age groups (range: 94.1–95.4%), with a numerical decrease in the number of MRI performed by age (mean: 0.25, 18–30 years; 0.20, 31–40 years; 0.16, 41–50 years; 0.14, ≥51 years). …”
  20. 12900

    Glucuronidation of β-lap in HT29 cell S9 fractions. by Huiying Liu (148261)

    Published 2015
    “…Results are presented as mean ± 3 SEM of three independent experiments (***P<0.001, UGT1A siRNA treatment vs. negative control cells).…”